India, Oct. 7 -- The following biotech stocks reached a 52-week high on October 6, 2026, driven by key catalysts such as newly announced research collaborations.
Pacific Biosciences of California Inc. (PACB) Pacific Biosciences, or PacBio, is a life science technology company that designs, develops, and manufactures sequencing solutions used in genetically complex problems.
The company's stock rose to a 52-week high of $3.44 on Tuesday.
On Tuesday, the company announced entering an agreement with TychoBio to generate full-length RNA data. The data can then be used to design RNA based therapies.
The collaboration plans to utilize PacBio's HiFi sequencing and the Kinnex long-read sequencing techniques.
Fortrea Holdings Inc. (FTRE)
Fortr...